Keywords: Mexico, Breast cancer, Market forecasts, Decision Resources, Novartis, Afinitor, Eisai, Halaven, Roche, Perjeta, Kadcyla

Growing patient population to drive Mexican breast cancer market

Article | 20 February 2013

Print This

An expanding patient population will largely contribute to the growth of the market for treating breast cancer in Mexico, according ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in